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Abstract
Introduction:  A  less  extensive  thyroidectomy  could  be  used  for  patients  in  the  low  risk  group.
Objective:  To  perform  a  critical  follow-up  after  lobectomy  with  isthmusectomy  for  the  treat-
ment of  papillary  thyroid  carcinoma  in  patients  with  a  single  nodule  limited  to  the  periphery
of the  lobe.
Methods:  Thirty-one  patients  with  thyroid  papillary  carcinoma  operated  on  till  1993  were
selected. They  had  undergone  lobectomy  with  isthmusectomy.  This  is  a  retrospective  cohort
study in  which  the  oncological  outcome  (contralateral  and  regional  recurrence)  and  the  reopera-
tion complications  (recurrent  nerve  paralysis/paresis  and  hypoparathyroidism)  were  evaluated.
Descriptive  analysis  was  employed.
Results:  In  the  last  decade  (2003--2013),  6  (20%)  contralateral  recurrences  were  observed  in  the
remaining lobe  and  in  1  of  these  cases  (3%),  contralateral  lymph  node  metastases  were  noted.
A completion  thyroidectomy  plus  lymphadenectomy  was  performed,  without  modiﬁcation  of
global survival.
Conclusion:  Because  of  the  rate  of  20%  of  contralateral  recurrence  after  a  20-year  follow-up,
we suggest  modiﬁcation  of  the  surgical  paradigm  for  total  thyroidectomy  as  an  initial  therapy.
© 2015  Published  by  Elsevier  Editora  Ltda.  on  behalf  of  Associação  Brasileira  de  Otorrino-
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Revisão  dos  resultados  de  sobrevida  a  20  anos  da  cirurgia  conservadora  no  carcinoma
papilífero  da  tireoide
Resumo
Introduc¸ão:  Uma  cirurgia  menos  extensa  da  glândula  tireoide  poderia  ser  utilizada  em  pacientes
do grupo  de  baixo  risco.
Objetivo:  Realizar  seguimento  crítico  após  hemitireoidectomia  para  tratamento  do  carcinoma
papilífero  de  tireoide  em  casos  de  nódulo  único  limitado  à  periferia  do  lobo.
Método:  Foram  selecionados  31  pacientes  portadores  de  carcinoma  papilífero  de  tireoide  oper-
ados, até  1993,  por  lobectomia  mais  istmectomia.  Trata-se  de  um  estudo  retrospectivo  de  coorte
sendo avaliados  o  resultado  oncológico  (recidiva  contralateral  e  regional)  e  complicac¸ões  de
reoperac¸ão (paralisia/paresia  de  nervo  recorrente  e  hipoparatireoidismo).  Utilizou-se  análise
descritiva.
Resultados:  Na  última  década,  foram  observados  6  (20%)  casos  de  recidivas  contralaterais  (lobo
remanescente)  sendo  que,  em  um  caso,  estava  acompanhado  de  metástases  linfonodais  con-
tralaterais  (3%),  sem  impacto  na  sobrevida  dos  pacientes  reoperados.
Conclusão:  A  ocorrência  de  20%  de  recidiva  contralateral  após  uma  média  evolutiva  de  20  anos
sugere revisão  do  paradigma  conservador  para  a  totalizac¸ão  imediata  da  tireoidectomia.
© 2015  Publicado  por  Elsevier  Editora  Ltda.  em  nome  da  Associação  Brasileira  de  Otorrino-
laringologia  e  Cirurgia  Cérvico-Facial.
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he  deﬁnition  of  the  therapeutic  paradigm  for  differenti-
ted  thyroid  cancers  still  remains  a  challenge  for  experts.
istorically,  the  low  aggressiveness  of  these  lesions,  which
resent  slow  growth,  has  led  clinicians  to  adopt  a  more  con-
ervative  approach  in  patients  with  a  single  nodule  located
n  the  periphery  of  the  thyroid  lobe,  oncologically  justify-
ng  the  conservation  of  the  remaining  lobe;  this  usually  was
ufﬁcient  tissue  to  maintain  function,  without  the  need  for
ormone  replacement  and  also  help  maintain  the  regula-
ion  of  thyroid-stimulating  hormone  (TSH).  Along  with  these
acts,  in  principle,  the  clinical  and  histological  absence  of
etastatic  regional  lymph  nodes  did  not  justify  elective  pro-
edures,  since  lymph  node  metastases  are  staging  ﬁndings,
ut  are  not  prognostic  in  the  short  and  medium  term.1--4
nother  consideration  is  that  a  partial  resection  decreases
he  potential  for  iatrogenic  complications  (especially  recur-
ent  nerve  injury  and  hypoparathyroidism),  which,  although
ncommon,  do  occur.
The  literature  reveals  that  patients  with  papillary  car-
inoma  undergoing  total  lobectomy  and  isthmectomy  have
quivalent  overall  survival  compared  to  patients  treated  by
otal  thyroidectomy.5 Currently,  over  70%  of  patients  with
apillary  carcinoma  of  thyroid  are  treated  with  total  thy-
oidectomy.  However,  many  patients  are  initially  treated  by
obectomy.  In  these  patients,  most  clinicians  would  favor
 total  thyroidectomy,  in  face  of  risk  of  disease  in  the
ontralateral  lobe.6 The  survival  of  patients  with  low-risk
umors  is  excellent,  regardless  of  the  extent  of  their  thy-
oidectomy.  Thus,  it  is  suggested  that  a  less  extensive
urgical  approach,  such  as  a  lobectomy  plus  isthmec-
omy,  could  be  used  in  patients  at  low  risk,  rather  than
he  systematic  recommendation  for  total  thyroidectomy.
nfortunately,  no  randomized  clinical  trials  comparing  the
w
t
T
offectiveness  of  these  two  forms  of  surgical  approaches  have
een  published;  thus,  surgeons  must  select  which  procedure
o  use,  based  on  their  own  opinion  and  from  the  evidence
f  retrospective  studies.7
In  this  sense,  during  the  period  from  1977  to  1997,  with  a
0--15-year  follow-up,  there  were  no  incidents  of  contralat-
ral  or  lymph  node  recurrence  until  2003.8 However,  the
acts  observed  in  our  study  indicate  a  need  for  reﬂection
n  the  indication  to  adopt  a  more  aggressive  initial  therapy.
he  question  that  remains  relates  to  the  possibility  that  a
econd  resection,  performed  decades  after  the  ﬁrst,  may  be
ecessary  in  adverse  clinical  conditions,  as  a  result  of  any
omorbid  condition  that  would  be  affecting  these  patients,
long  with  possible  iatrogenic  complications  resulting  from
he  handling  of  the  previously  treated  operative  ﬁeld.9
This  study  aimed  to  evaluate  the  survival  results  20  years
fter  lobectomy  plus  isthmectomy  for  patients  with  papillary
hyroid  carcinoma.
ethods
his  study  was  approved  by  the  Ethics  Committee  on
esearch  of  the  institution  in  which  it  was  conducted,  under
o.  222.
One  hundred  and  ﬁve  medical  records  of  patients  with
apillary  thyroid  carcinoma  submitted  to  surgery  before  the
ear  1993  were  analyzed.  Of  these,  31  cases  which  clini-
ally  and  ultrasonographically  presented  a  node  limited  to
 gland  lobe  were  selected;  these  patients  had  a  minimum
f  ﬁve  years  follow-up  and  were  submitted  to  an  ipsilat-
ral  lobectomy  together  with  an  isthmectomy.  Thus,  this
as  a  cohort  (with  follow-up)  study  of  patients  submitted
o  a  hemithyroidectomy  for  papillary  thyroid  carcinoma.
he  effects  studied  were:  oncological  outcome,  through  the
ccurrence  of  contralateral  and  regional  recurrence  and,  in
Review  of  survival  rates  20-years  after  conservative  surgery  
Table  1  Patient  distribution  according  to  gender  and  age.
Male  Female  Total
≥45  years  3  (21%)  11  (79%)  14  (45%)
<45 years  4  (23%)  13  (77%)  17  (55%)
Total 7  (22%)  24  (78%)  31  (100%)
Table  2  Patient  distribution  according  to  tumor  size.
Diameter  (cm)  Number  (%)
<1  3  (9)
g
h
f
i
t
r
l
(
u
r
s
p
m
ﬁ
t
t
T
s
d
s
r
l
v
w
c
o
r
m
H
t
m
m
t
r
y
t
2
a
n
t
ﬁ
r
b
t
b
p
i
e
l
i
c
s
I1--2 15  (48)
>2 13  (41)
those  cases  of  reoperation,  potential  complications  (paral-
ysis/paresis  of  recurrent  nerve  and  clinical  and  laboratory
hypoparathyroidism)  were  evaluated.  Descriptive  statistics
were  applied.
Results
Of  the  31  patients,  seven  (22%)  were  male  and  24  (78%)
female,  ranging  between  16  and  79  years.  Seventeen
patients  (55%)  belonged  to  a  group  under  45  years  and  14
(45%)  were  over  45  years  (Table  1).
The  nodes  had  a  size  between  1  cm  and  5  cm  in  their
longest  axis.  Nodes  with  a  mean  diameter  of  2.2  cm  (Table  2)
prevailed.  Six  patients  (19%)  of  this  series  showed  metastatic
cervical  lymph  node  enlargement,  and  underwent  func-
tional  neck  dissection  in  association  with  thyroidectomy.  All
patients  are  alive;  in  six  (20%)  relapse  occurred  in  the  resid-
ual  lobe,  followed  by  surgical  rescue,  with  100%  survival.
Regarding  complications,  one  patient  (3%)  had  transient
dysphonia,  with  unilateral  vocal  fold  paresis,  which  resolved
spontaneously.  There  were  no  cases  of  transient  or  perma-
nent  hypoparathyroidism.
Mean  follow-up  was  20  years.  Ten  patients  (32%)  were
monitored  between  10  and  15  years,  10  (32%)  had  follow-
ups  over  15  years,  and  11  (37%)  over  20  years.  There  were  no
cases  of  local  or  regional  recurrence  or  of  distant  metastasis,
with  all  patients  asymptomatic  and  without  the  disease.
Discussion
Because  of  the  difference  of  opinion,  the  hypothesis  that
treatment  outcomes  are  comparable  with  both  methods,  but
with  fewer  complications  for  partial  thyroidectomy  (lobec-
tomy  plus  isthmectomy),10 for  many  years  the  authors’
clinical  reasoning  spoke  in  favor  of  the  latter  conduct  in
this  service.  However,  it  was  decided  to  review  this  series
of  papillary  thyroid  carcinoma  limited  to  only  one  lobe
and  treated  by  partial  thyroidectomy,  with  a  minimum
evolution  of  ﬁve  years,  and  to  check  the  incidence  and  loca-
tion  of  recurrences  and  distant  metastases,  postoperative
complications,  and  survival  results  after  ﬁve,  10,  15,  and  20
years.
Disagreements  do  not  occur  when  facing  locally  advanced
tumors  with  inﬁltration  of  adjacent  tissues  and/or  with
regional  or  distant  metastases.11 The  problem  occurs  in  that
a
b
c
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roup  of  patients  considered  as  low  risk  cases.  No  objection
as  been  found  to  the  statement  that  the  treatment  of  dif-
erentiated  thyroid  carcinoma  is  primarily  surgical  --  what
s  under  discussion  is  the  extent  of  the  surgical  approach
o  this  gland  and  lymph  nodes,  and  hence  the  ramiﬁcations
elated  to  the  monitoring  of  these  patients.12
In  the  initial  cases,  each  node  measured  1--5  cm  in  its
ongest  axis,  with  a  mean  diameter  of  2.2  cm.  Six  patients
19%)  had  metastatic  cervical  lymph  node  enlargement  and
nderwent  functional  neck  dissection  plus  a  partial  thy-
oidectomy.  Even  though  there  were  nodes  up  to  5  cm  in
ize  observed  at  the  time  of  the  procedure,  in  cases  of
apillary  carcinoma  the  incidence  of  distant  metastasis  is
inimal,  allowing  the  selection  of  the  partial  procedure  as
rst  choice.  The  use  of  iodine  I131 is  questionable  because,  in
hese  patients,  distant  dissemination  usually  does  not  occur;
herefore,  this  practice  is  still  considered  controversial.13,14
he  fact  that  six  patients  (19%)  had  cervical  metasta-
is  without  capsular  rupture  makes  the  functional  neck
issection  a  perfectly  acceptable  procedure.  But  the  empha-
is  of  this  study  was  in  the  assessment  of  long-term
esults.
This  series  demonstrated  that  80%  of  patients  had  nodes
arger  than  1  cm,  and  22%  had  histologically  positive  cer-
ical  metastases,  treated  by  neck  dissection.  All  patients
ere  followed  for  over  ﬁve  years,  and  more  than  60%  of  the
ases  were  followed  for  over  ten  years.  There  was  no  local
r  regional  recurrence.
Tumor  size  is  considered  an  important  indicator  of  risk  for
ecurrence  in  the  contralateral  lobe,  as  well  as  the  involve-
ent  of  a  regional  lymph  node  and  distant  metastasis.
owever,  microcarcinomata  with  clinical  manifestations,
hat  is,  the  presence  of  regional  or  distant  metastasis,  are
ore  aggressive  compared  to  asymptomatic  microcarcino-
ata,  which  tend  to  have  a  good  outcome  with  conservative
reatment.15
Over  the  past  ten  years,  the  presence  of  contralateral
ecurrence  was  found  in  six  patients  (all  with  more  than  20
ears  of  follow-up),  which  represents  20%  (6/31).  Although
he  survival  rate  was  100%  (thanks  to  surgical  rescue),  a
0%  recurrence  rate  suggests  a rethinking  of  the  procedures
dopted  in  the  ﬁrst  period  of  this  study.  Thus,  in  view  of  the
eed  for  a complete  thyroidectomy,  we  wanted  to  revisit
he  initial  plan  of  performing  the  hemithyroidectomy  as  the
rst  therapeutic  approach  and  have  come  to  consider  total
esection  of  the  thyroid  gland  from  the  beginning.  We  com-
ine  this  with  hormone  therapy  in  young  patients  who,  due
o  their  expected  long  survival,  might  need  a  second  surgery
ecause  of  local  recurrence  in  the  event  of  a  less  than  com-
lete  thyroidectomy.
Lymph  node  metastases,  can  be  detected  early  with  the
maging  methods  now  available,  more  recently  by  positron
mission  tomography/computed  tomography  at  the  regional
evel  and,  more  rarely,  for  distant  manifestations.  However,
n  the  initial  cases  of  the  six  patients  with  recurrence  in  the
ontralateral  lobe  (the  emphasis  of  the  authors’  previous
tudy),8 only  in  one  were  contralateral  lymph  nodes  in  levels
V--V  detected.  The  development  of  these  recurrences  was
ccompanied  by  a  slight  increase  in  thyroglobulin,  despite
eing  usually  valued  as  the  marker  of  recurrence.16--19 In
ontrast  to  other  head  and  neck  cancers,  the  various  surgi-
al  therapeutic  approaches  for  differentiated  thyroid  cancer
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192  
ave  good  survival  results,  with  some  exceptions,  regardless
f  the  approach  performed.
Epidemiological  data  suggest  the  existence  of  regional
nd  international  differences  with  respect  to  tumor  biology.
hile  U.S.  studies  could  not  demonstrate  the  advantages
f  a  total  thyroidectomy  and  of  neck  dissection,  compared
o  less  extensive  procedures,  especially  in  T2/T3  cases,20
uropean  studies  show  an  increase  in  survival  rates  when
ymphadenectomy  was  performed  in  addition  to  the  total
hyroidectomy.21 Regarding  multicentric  foci,  it  is  known
hat  the  potential  for  existence  of  tumor  foci  in  a  remaining
ontralateral  lobe  is  variable.  Autopsy  studies  have  detected
icroscopic  foci  of  papillary  thyroid  carcinoma  as  inciden-
al  ﬁndings  in  more  than  25%  of  patients  killed  by  other
iseases,  reaching  up  to  90%  of  cases  in  different  centers.
owever,  the  authors  of  this  study  have  always  reported
ilateral  rates  lower  than  those  for  local  recurrence.  This
eans  that  the  presence  of  a  contralateral  microscopic
umor  is  not  an  indication  that  there  will  necessarily  be  a
linical  manifestation  of  this  residual  tumor  through  local
ecurrence;  and  if  this  does  happen,  that  there  will  be  a
igher  rate  of  death  from  cancer.
Nonetheless,  the  fear  of  multicentric  foci  should  be
ncluded  among  the  reasons  for  routinely  performing  a
otal  thyroidectomy  in  patients  with  papillary  thyroid  car-
inoma,  since  it  could  cause  recurrence  and  death;  the
isk  of  a  transformation  of  a  non-resected  microscopic
umor  to  an  anaplastic  malignant  form;  and  the  opportu-
ity  to  monitor  thyroglobulin,  a  marker  of  recurrence  of  this
isease.22
The  rates  of  thyroidectomy  complications  have  been
educed  by  improvements  in  surgical  technique  and  the
xperience  of  specialized  centers.  Nevertheless,  tempo-
ary  paresis  of  the  recurrent  nerve  and  hypoparathyroidism
re  the  main  complications  in  patients  treated  with  total
hyroidectomy.  Thus,  when  comparing  complications  in
he  groups  who  underwent  primary  total  thyroidectomy
ersus  total  thyroidectomy  as  a  secondary  procedure  for
 well-differentiated  thyroid  carcinoma,  no  signiﬁcant
ifference  was  noted,  except  for  a  transient  recurrent
aresis,  which  occurred  more  often  in  the  second  group.23
hus,  this  does  not  seem  to  be  a  criterion  for  decision
aking.
Previously,  this  service’s  surgical  preference  was  lobec-
omy  plus  isthmectomy  in  patients  with  papillary  carcinomas
imited  to  a  glandular  lobe,  with  a  virtually  nonexistent
omplication  rate.  However,  the  long  term  contralateral
ecurrence  rate  of  20%  of  led  us  to  revise  this,  in  favor
f  a  initial  total  thyroidectomy.  For  the  specialist  who
reats  patients  with  thyroid  cancer,  it  is  critical  to  take  into
ccount  the  experience  of  specialized  centers,  thus  building
is/her  own  experience,  since  the  completion  of  random-
zed  prospective  studies  although  a  desirable  practice,  has
uestionable  feasibility.
onclusionhe  occurrence  of  20%  contralateral  recurrence  after  an
verage  of  20  years  of  evolution  suggests  review  of  the
onservative  paradigm  for  immediate  completion  of  thy-
oidectomy.
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